Plans are underway for the NCC Research Fund to be subsumed under the umbrella of SingHealth Fund (SHF) as part of the NCCS Cancer Fund in the next few years. NCCS’ Community Cancer Fund was subsumed under SHF as the NCCS Cancer Fund earlier. The causes that the NCCS Cancer Fund supports remain unchanged from those as intended by NCCS for its charitable funds, namely cancer research, cancer patient support and cancer education. Donors who have been giving regularly to the NCC Research Fund will be notified in due course.
Established in 2005, the NCC Research Fund serves as the flagship fundraising and grant-making channel of our Centre by providing seeding and bridging funds for an array of translational and clinical research programmes.
The NCC Research Fund fulfils three objectives:
With cancer accounting for more than one in four deaths in Singapore, the Centre plays a pivotal role in the holistic care and multidisciplinary-based treatment of cancer patients. Innovative medicine requires quality research and clinical research is an arduous undertaking. Our doctor-scientists require ample philanthropic support and public understanding in order to usher medical breakthroughs for the benefit of the community.
We firmly believe that today’s research will pave the way for a cure for cancer tomorrow.
Through your support in cancer research, there is hope of overcoming the greatest threat to lives. More lives can be saved.
NCC Research Fund is registered under the Charities Act as an Institution of Public Character (IPC) with an independent Board of Trustees.
Today's Research. Tomorrow's Cure. ™
Financial Information
Please click here to view.
Non-financial Information
FY2017 in Year Review | FY2016 Year in Review | FY2014-2015 Year in Review |
![]() |
![]() |
![]() |
(As the PDF file size is 3MB, it may take a few minutes to load.)
Charity Status
IPC Status
Chairperson
Madam Ho Geok Choo
CEO,
Human Capital (Singapore) Pte Ltd
Members
Mr George Thia Peng Heok
Business Consultant, Asiainc Private Limited and GAAB Private Limited;
Non-Independent Non-Executive Director, CH Offshore Limited;
Independent Non-Executive Director, Yoma Strategic Holdings Limited
Mr Kaka Singh
Chairman and Senior Partner,
RSM Chio Lim LLP
Mr Ng Boon Yew
Chairman and CEO,
Raffles Campus Pte Ltd
Prof Soo Khee Chee
Surgeon,
Soo Khee Chee Surgery
Prof Tan Ser Kiat
Emeritus Consultant,
Singapore General Hospital
Prof William Hwang
Senior Advisor, SingHealth,
Co-Director, Regenerative Medicine Institute of Singapore (REMEDIS),
Senior Consultant, Department of Haematology, NCCS and SGH
Mr Harry Ng
Executive Director,
HLM (International) Corporate Services Pte. Ltd
Prof Lim Soon Thye
Chief Executive Officer, NCCS, & Deputy Group Chief Executive Officer (Research, Education & Innovation), SingHealth
Co-opted Members
Mr Vikna Rajah
Head Tax & Trust, Co-head Private Wealth,
Rajah & Tann Singapore LLP
Ms Lim Lei Theng
Partner
Allen & Gledhill LLP
Chairperson
Mr George Thia Peng Heok
Business Consultant, Asiainc Private Limited and GAAB Private Limited;
Non-Independent Non-Executive Director, CH Offshore Limited;
Independent Non-Executive Director, Yoma Strategic Holdings Limited
Members
Mr Seow Choong Huei
Founder,
8818 Enterprises Private Limited
Mr Ng Boon Yew
Chairman and CEO,
Raffles Campus Pte Ltd
Mr Vikna Rajah
Head Tax & Trust, Co-head Private Wealth,
Rajah & Tann Singapore LLP
Chairperson
Mr Harry Ng
Executive Director,
HLM (International) Corporate Services Pte. Ltd
Members
Mr Kaka Singh
Chairman and Senior Partner,
RSM Chio Lim LLP
Mr Khor Boon Hong
Partner, Baker Tilly TFW LLP
Chairperson
Prof Lim Soon Thye
CEO, NCCS
Members
Prof Tan Ser Kiat
Emeritus Consultant,
Singapore General Hospital
Mr. Suhaimi Zainul-Abidin
Director/CEO,
Quantedge Capital Pte Ltd
Mr Perry Lim
Executive Director,
Royal Golden Eagle
Madam Ho Geok Choo
CEO,
Human Capital (Singapore) Pte Ltd